DatasetName,PCBP2_S(18) PCBP2_S(184) PCBP2_S(185) PCBP2_S(187) PCBP2_S(189) PCBP2_S(272) PCBP2_S(365) PCBP2_T(10) PCBP2_Y(13),PCBP2_C(169) PCBP2_C(171) PCBP2_C(173) PCBP2_S(11) PCBP2_S(13) PCBP2_S(171) PCBP2_S(173) PCBP2_S(183) PCBP2_S(188) PCBP2_S(19) PCBP2_S(20) PCBP2_S(231) PCBP2_S(27) PCBP2_S(35) PCBP2_S(357) PCBP2_S(364) PCBP2_Y(182)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.6544388119730363,
SR2019_MCF7_Biol_repl_3,0.6818881965198642,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,0.6841177547705339,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.6925845467565489,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6913553550233736,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6668634705155606,0.5053191558679335
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.6896478452459921,
SR2019_MDAMB231_Biol_repl_4,0.6871425243989658,
GF2025_P2_Sph,0.6772727174175909,0.5134103741756858
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,0.6766387862219401,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6893608156538211,0.5102786696130089
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.6893441757124553,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.6780135119109372,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,0.6917125929022263,0.5186266503146145
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.6820756763356474,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6964173791899533,0.4738923602602612
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.6886181092874735,0.5100309824631001
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6725936893054951,0.5176507288080081
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.6617208234514194,0.519311973232743
RB2022_5_PreSprint,0.6876541826205115,
PG2020_Intensity 8h_C,0.6744228517470943,0.49123973408581395
AH2018_SILAC_MR_2_N,0.6911856315185912,0.5109458596797721
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,0.5149675619810045
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.6681201429006685,0.5042212051662573
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.6798217276200846,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.6583170004076822,
GF2025_P6_Sph,0.6830467395789144,0.5132147785636256
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.6665894871934083,0.504726709180308
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6928170875092119,0.5268776763273753
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.6846285728604967,0.5096461327768346
WZ2023_Pu_005_10min,0.6897811534247461,0.5236061709232152
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6811288693596518,0.5032028890225378
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.6506954129845484,0.5092057101084098
WZ2023_Pu_025_30min,0.6987182788927223,0.5183497846912436
AH2018_SILAC_MR_2_X,0.6868097757753997,0.5107318477236797
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6554461111389244,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.6595345346954689,
EJN2021_3_Rest_Basal,0.6837780009682968,
CR2017_Ratio Replicate 1.3,0.6862204899466462,0.5105594902184583
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6656144431775481,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.6512837001575534,
AH2018_LFQ_1_C,0.6945168776828772,0.5059308741380526
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6813987293584076,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6915237326156181,0.5229119835193787
CK2022_11 40-1,0.6807809767254367,0.5036967720662828
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5123018726154536
FSO2013_Ratio H/L normalized Rep2,0.6697443885914752,
WZ2023_Pu_005_20min,0.6932330377526247,0.518518222309532
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6674964913817258,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.6960643282306979,0.48991362058960075
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.6620599649024985,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.6930913856765238,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6913377613106747,
CK2022_1 200-1,0.6705305964902151,0.5033380559347355
PG2020_Intensity Mock_10h_D,0.7010197324962634,0.5159549241672674
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,0.507431677368439
RB2022_6_RecoveryEndurance,0.6833294538472348,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,0.6795672512626704,0.5127511444934452
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6634719390892714,0.5030685356573078
KBE2022_Log2_Ex_8_T,0.6839400996379758,0.5093950801790993
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6953035516789193,0.5015705556831274
CK2022_3 40-1,0.6856792852238225,0.5049119511094816
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.6729440192085504,0.5052403157177608
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.6702303691292644,0.5184549681636678
EJN2021_5_Rest_Basal,0.6820622114264308,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,0.6816905914866506,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,0.529402779461898
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6661901601835154,0.49937331226634224
SR2019_Hs578T_Biol_repl_3,0.6795908243972177,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.6735450530658595,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.6772174528905283,0.5107039275478731
HS2024_8_I_T3,,
CF2017_EOC 3,0.6508530543581165,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.6706277879729092,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6927076494925631,0.529461200379997
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6856472017116851,0.5052923879618791
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.6920361098237644,
KS2014_Intensity N3,,0.5178946241765527
RB2022_4_RecoveryEndurance,0.6900185613609834,
RB2022_5_RecoveryEndurance,0.6872627152115766,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.6922640837546736,
FSO2013_Ratio H/M normalized Rep2,0.6709038734839687,
RAM2015_Log2 A,0.6661678294541381,0.5125969134968176
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,0.5098784077634093
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.6838730096051043,0.5021478013912075
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6658347161870775,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6840186981100328,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6891225832603607,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6921451097351494,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.505864872111136
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.6756859890548471,
AH2018_SILAC_IT_3_X,0.665585666248818,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.6661500138350622,0.49463682626127864
FSO2013_Ratio M/L normalized Rep2,0.68046090553577,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5094189374984306
SR2019_HCC1954_Biol_repl_2,0.6840419751457296,
CK2022_14 40-1,0.6868081230291295,0.5051594242003059
RB2022_6_PreSprint,0.6896789183641414,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.680680734907364,0.5039469404283855
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6871075986876357,
DL2023_control-1,,
AR2021_ALG 10 μM,0.667762243816371,0.5283206337685916
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6664116596951529,
EJN2021_4_Rest_Ins,0.6880864028951813,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.6704369985901519,0.5202153272099057
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.6880380704771176,
HH2022_Reporter intensity 3,,0.5208426003842755
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.6921576274491898,
JW2021_After_3,,
GF2025_P8_Sph,0.676275198404739,0.5158381161668456
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.6669145324555396,0.5010132599427353
CK2022_12 200-1,0.6666044241142421,0.5015849461800868
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5058764008519001
WZ2023_Su_010_20min,0.6925922900901671,0.5212308194833802
AH2018_TMTMS2_2_N,0.6744875799645143,0.5193098129967872
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6891263277660769,0.51005952175839
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5110441461174167
AH2018_TMTMS3_Pool,0.6556437339756271,0.5213383598080102
KS2014_Intensity N4,,0.5199177207791106
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.6905320923732101,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.6652864906683512,
CK2022_14 200-1,0.6727358347918653,0.5026671698782962
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.6672851962253589,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.6758831704778093,0.521589365461651
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.6865756251392878,0.5184322685391769
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.6867757984477867,
SR2019_LM2_Biol_repl_4,0.6851478801169435,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.6916766402586509,
GF2025_P1_Adh,0.6611602173887071,0.5135843065079878
GF2025_P1_Sph,0.6716209318141478,0.5143539073122205
EJN2021_5_Ex_Basal,0.6847493736248951,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6927186857269503,0.5268365712443487
CF2017_EOC 1,0.6778462312701329,
CK2022_3 200-1,0.6707538965603175,0.5028321824826859
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.6765983251423825,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,0.6769174096182445,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.6859760067415143,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.6818365384287778,
CK2022_2 40-1,0.6849614398337468,0.5043557984750975
RB2022_1_PostSprint,0.6601175281409077,
CK2022_4 200-1,0.6703146077252738,0.5030528648987913
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6924833038668553,
AR2021_ALG 1 μM,0.6624901410267723,0.49311898781836566
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.6905419039785101,
EJN2021_1_Rest_Basal,0.6825559586449417,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.6539307536577158,0.5154946002481601
CK2022_9 16-1,0.6830995351348936,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.6726052655726135,0.5017270580456511
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.6759957238988393,0.5101842649064983
CK2022_16 16-1,0.6919604280245296,
FS2019_db/db3,,
CK2022_15 40-1,0.6861818366343077,0.5047232649114388
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.693057603071932,0.5213741277022043
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.6875022805854827,0.5106892838465357
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6743387474117186,0.5209029852169782
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,0.6782698952192251,0.5136511644477345
KBE2022_Log2_Ex_40_U,0.6818085990228931,0.5089599994991121
AH2018_LFQ_M_1_N,0.6935301847161901,0.4791183311931593
KBE2022_Log2_Ex_27_U,0.691179628732278,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6921300589293051,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.6635657480984629,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.6808645519863065,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.6779880425435415,0.5121268353572255
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.6849351711709399,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6902386514517082,0.508425572106092
SR2019_SKBR3_Biol_repl_3,0.6753897092934804,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.6733959034147454,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6815167123261069,0.5035124354618524
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6654891068219472,0.5055318915625123
HH2022_Reporter intensity 6,,0.5056188494450626
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6671947906905208,0.508750277078901
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.674256603334477,0.5156881080230581
GF2025_P3_Adh,0.661232417217743,0.5177731695923393
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6716897509626456,0.5211266268801085
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.672670034751557,0.5084741934761716
KBE2022_Log2_Ex_19_U,0.689777594927386,0.5105199605055822
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.6676920557396058,
YA2020_Reporter_intensity_Cancer_No.1,0.6676204608882816,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.5094254946922264
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.6800307929871713,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.6951696849037192,
RB2022_7_RecoverySprint,0.6803566694032545,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6944412549646903,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.5238306868410683
HH2022_Reporter intensity 1,,0.5197280634452618
HH2022_Reporter intensity 2,,0.5196500903102701
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,0.6792211333036309,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,0.6839611513576559,
RB2022_4_RecoveryStrength,0.673186952788888,
CR2017_Ratio Replicate 2,0.6788577677052848,0.5134760054990043
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.6512946081933133,
AR2021_KD 72h,0.6613632776148264,0.49619379078013437
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6846518748768865,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6726535431721667,0.522242422321408
KBE2022_Log2_Ex_9_U,0.6861799184908145,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.6866506794450093,0.5097227329889593
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.6762284139514949,0.5152013199237265
CF2017_OSE 29,0.666482668620753,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.6553545858161658,0.48987088697263204
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.6757569575715672,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6877756319483651,0.5054231048275066
RB2022_7_RecoveryEndurance,0.6872089579065884,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.6851947149226374,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.6863454949401098,0.508564944001715
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6886871112410207,0.511098378735461
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5057548011461109
RB2022_1_PreSprint,0.6823376224540744,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6723303926439201,0.5043558713405878
CK2022_5 200-1,0.672965426172811,0.5042306265942137
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.6700776364034498,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6937336651155127,0.4968904323169822
AH2018_SILAC_MR_1_X,0.6923968192423807,0.5101549711094708
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6899574127951527,0.5108963043365566
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.687047161164906,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.6743606985385452,
CK2022_4 16-1,0.6907766038405927,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.6852383280746408,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6922115787269862,0.48211312749981056
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.6762415119896693,0.5038473071408778
FSO2013_Ratio H/L normalized Rep3,0.6733904223999025,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6851915118339552,
AH2018_SILAC_IT_2_N,0.6615882041578919,
AH2018_SILAC_IT_1_X,0.665465294743838,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.6608101771021899,0.5161762438844333
WZ2023_Pe_025_20min,0.6934619823735536,0.5297726495241241
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,0.49264987781726577
AH2018_LFQ_2_N,0.6824838024227391,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.673457090675701,0.5165275932116895
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6921120388088847,0.5126512091463696
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6609889936071458,0.5026338086885089
WZ2023_Su_025_10min,0.693704980153276,0.5185189230252909
AH2018_LFQ_IT_4_X,0.665617668806734,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.6823858054493713,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6930452054988165,0.5120566933517257
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.6848670714351854,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.6876396551097047,
KS2014_Intensity,,0.5208250270336355
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.6670606109479758,0.48810229316875725
LY2019_P7+,0.6691188031582304,0.5084170275258828
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,0.6866454817572709,0.5052774386075392
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,0.5145242242311125
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6850561688134302,0.5109189372259467
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.6655254444247672,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6896680049674327,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.667021965068052,
CR2017_Ratio Replicate 1.1,0.6874740847037669,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.6722986823196584,0.5025151522984266
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.6862362488980813,0.5084306640929339
CK2022_6 200-1,0.672192753269959,0.5045931253112955
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6774284782716071,0.5227462281095014
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.6705083966614995,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,0.5088255648498586
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.6845897660216232,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.6878393204639253,
PG2020_Intensity 2h_D,0.6863023012435499,0.5143743027541055
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6724505989135189,0.504577058868295
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.6720690782011172,0.5093482283076674
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6861489266524248,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.688346702021749,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.6923484810474163,0.5110248754857126
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.6665237816810663,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6836544928275097,
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.6813118954694785,0.5227501812186967
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.6735879605149939,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6875420228734244,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.6717222727428201,
CR2017_Ratio Replicate 2.3,0.6680126027410194,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6639094675082924,0.5195026534241203
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.6640702638625812,0.5135608380127522
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6846424821052042,0.49380540073527884
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6834740783622829,0.5092464835574705
CK2022_2 16-1,0.6902040569701309,
RAM2015_Log2 B,0.6660340626359916,0.505225848634312
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.6831899154731855,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.6952323359978237,0.5155528948161976
WZ2023_Su_025_30min,0.6926541864833906,0.5232234346449118
AH2018_LFQ_4_N,0.690769024621245,
CR2017_Ratio Replicate 1.2,0.6575198694399531,0.5051943364106496
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.6708967521932698,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.49735271485625676
AH2018_SILAC_M_1_X,0.691441744982153,
RB2022_7_PreEndurance,0.6768406168033002,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.6741428552018015,0.5154808129444252
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6675445263625597,0.51122531691109
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,0.5096214333021625
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.6605168626384734,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.6745965097979181,0.52202672046612
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5141138404908712
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.687113642955032,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.6657879247575039,0.5141660418660388
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,0.6814180729872209,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,0.6903105726562038,
AH2018_LFQ_M_4_N,0.6926900439802286,0.49543458714410216
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.6803191824889179,0.48732916833637946
AH2018_LFQ_2_X,0.6922495224749459,
PG2020_Intensity 2h_B,0.6642187547178768,0.5138946882036644
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.662068810383625,
KS2014_Intensity E15_3,,0.5121959538775084
GF2025_P3_Sph,0.6756672992787803,0.5165293725645828
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6914637160567477,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.511761851339759
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6663575902920149,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6910415165961359,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.6794485983250931,
ZQ2022_N1,0.6629599838875982,0.5074180162233414
LY2019_P6-,0.6793835723132677,0.5151016176188205
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.6817640047354758,0.484654691830402
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.6883565376766213,0.509229759731281
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.6829352536742802,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.688489739537775,0.5053218446088298
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.6764347328837899,0.5088692983354461
SR2019_BT549_Biol_repl_2,0.6879319118148403,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6926703715490353,0.5129133399069827
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.6745386034723088,0.5098913431066338
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,0.5133135700520215
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.6481085660272279,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.6866919471416927,0.5050131155392212
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.6578884513519259,0.5000219992898733
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.6849350248451782,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.6852715925043857,
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.6663670310775666,
AH2018_SILAC_MR_3_C,0.6930261350374896,0.5110564823088433
AH2018_LFQ_M_4_C,0.6892002071409148,0.4961498366566328
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.6881144120177773,0.5055134720840448
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6879674479112956,
LY2019_P3-,0.6598984749795043,0.5128514814086739
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.6846245482059279,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6936355025023948,0.5265984997739098
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.6835122734066508,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.6852265829698676,0.5128763964372544
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6922490878095908,0.5224649580505121
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,0.51541613592201
GF2025_P10_Adh,0.6487724515080594,0.5151643226428209
RB2022_1_RecoveryStrength,0.6806777945611326,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6781713454485018,0.5189602367132576
RB2022_4_PreSprint,0.6840094140360728,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.6728697985457449,0.5209806717656891
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.6824351023973954,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6919041918798903,
LY2019_P8+,0.6769644752737732,0.5198673670983146
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5036527601155946
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6912440244831521,0.491008405729783
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6845039869993776,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.6719375657613716,
LY2019_P2-,0.6734549403079029,0.5194592308444977
AH2018_LFQ_IT_1_X,0.6915887713900146,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6946524119659956,0.5262480884032604
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,0.5130288608598872
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,0.680062534937803,0.5146514486374503
CK2022_4 40-1,0.6858302675550534,0.5044624789250182
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6830285125054908,
AH2018_TMTMS3_3_N,0.6737700207340596,0.5189012755719853
SR2019_HCC1419_Biol_repl_2,0.677498880077303,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6960806480147097,0.5047298803184378
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.682108049374491,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6943632395351983,0.5280573022579487
KS2014_Intensity C2,,0.5139186465667565
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6813882755844047,
CK2022_9 200-1,0.6662427463406481,0.5013955266028524
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6662648980330808,0.5016190241172097
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.6730312260623693,0.5018768983472117
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.6793139132850567,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.49957319746426393
ZQ2022_C3,0.6719550171698085,0.513897921555237
EJN2021_3_Rest_Ins,0.6859838967784841,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6837767104552938,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.693281196277485,0.5186805911262448
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5242990422940172
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6737427690143112,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6951971074893257,0.5103494910017863
LATM2013_Log2 Ratio (Medium/Light) Forward,0.6704356511460091,
PG2020_Intensity 2h_A,0.6712948563868539,0.5079774935876178
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6832446986255989,0.5107448790657536
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.6672881517119476,0.5104798687885497
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.6816228199718588,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.6811239840077697,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.684804221999349,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6937500642164349,0.523714761586767
KBE2022_Log2_Ex_29_U,0.683921406051351,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6942713611920412,0.4797944421414734
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.6715880523836213,0.5016072705039097
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.6836999398432989,0.50965937254745
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.6573929986024699,0.48326880589296145
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.6671179058343587,
CK2022_2 200-1,0.668918582087463,0.5022404150791071
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6931269147129909,0.5224384175298399
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.6833198691993354,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.6711368249882066,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.6863655159321058,0.5105240195850744
WZ2023_Pe_010_20min,0.694028278975756,0.5285323358090898
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.6847691905592804,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.5104593092408801
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.5157572128806307
FSO2013_Ratio H/M normalized Rep3___1,0.6515480705617217,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6803288060735506,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6940903729213816,0.5228157972510917
PG2020_Intensity 6h_C,0.6773513604477679,0.495015782524919
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,0.518922150261033
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6838305879094965,0.49467029986838656
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6743337378637225,0.516798558682724
CK2022_15 16-1,0.6903958139730366,
CK2022_3 16-1,0.6905700885295132,
LY2019_P4-,0.6754079613100356,0.502527554473742
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.6702961079856421,0.518313615153654
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.6711500872334529,0.5166736805001133
CK2022_10 16-1,0.682323610067284,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5059406974645713
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,0.684421415808446,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.6670422498506199,0.5086921572456192
CF2017_EOC 2,0.6689897150784496,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.6922690504973724,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.6828423460657874,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.6923805132446633,
ZX2022_CB treated Replicate 1,0.6640762050532474,0.5033251769423998
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.5201539095863144
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.6791331986370759,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.674833228251665,0.5184917675735072
AR2021_L41 1 μM,0.6705397153447635,0.5065151668380394
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6724361595764254,0.5200810316910807
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,0.5067057269929398
ZX2022_Control Replicate 3,0.6672913843511838,0.5046299250243345
KS2014_Intensity C4,,0.5093757766796478
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6854836328704279,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6929518518161233,0.4937785266516787
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.6925687076038193,
WZ2023_Pu_025_10min,0.6938362084208083,0.5253024384120858
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.6544188249215703,
SR2019_JIMT1_Biol_repl_4,0.6663271007411881,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.6390384166469522,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6941886105711509,0.5291423651889606
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,0.5099460219976055
ZQ2022_N3,0.6743786869902376,0.5069947445279217
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.6814936876379879,0.5042070354292274
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.667796088948998,0.505645952653073
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.6872060167141579,0.5048431686709992
AH2018_SILAC_IT_2_C,0.691901727850356,
CK2022_5 40-1,0.6880806749737179,0.5054991164951981
AH2018_LFQ_3_X,0.6856768528976214,0.4839639290411037
UK2020_UA_3,,
LY2019_P7-,0.6748881917524049,0.5086180745061145
GF2025_P5_Adh,0.6695735023883461,0.5218305920704585
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.6740130491061268,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.680357824943718,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6839343844376234,
ZQ2022_C1,0.6728614026980038,0.518590574013535
CR2017_Ratio Replicate 2.1,0.6668051590092006,0.5060036230442925
PG2020_Intensity CT_B,0.6686982258533347,0.5176423702509908
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6892555489420273,0.5109113935067399
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6909520205099223,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6876858297875141,0.495229829894546
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.6676432418619404,0.5145966817092869
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.6854940097785766,0.510015320157336
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.6920755855114762,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6728201312336166,0.510453196887005
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.6817936178630379,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,0.6762265459015508,0.5200258332967905
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.6845610770019177,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.4910833634044671
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.6745275439021714,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6915942311021378,
PG2020_Intensity 10h_B,0.6538509807799058,0.4855589285622077
AH2018_TMTMS3_1_X,0.666135221870681,0.5244808031339231
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,0.6791112968533971,
PG2020_Intensity 6h_A,0.6761609311488527,0.5089319835987238
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.6864912710360103,0.509619024349125
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.6639196235815568,0.5124145141631137
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
